Judah Mwaura, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 11685 Holmes Ave, Mira Loma, CA 91752 Phone: 951-703-9023 |
Dawn Camille Chambers, LVN Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 5640 W Homecoming Cir, Apt. A, Mira Loma, CA 91752 Phone: 909-684-9246 |
Isabella Mwaura, Licensed Vocational Nurse Medicare: Not Enrolled in Medicare Practice Location: 11685 Holmes Ave, Mira Loma, CA 91752 Phone: 562-298-6449 |
News Archive
Findings of a preliminary study in this week's issue of THE LANCET suggest that transplanted adult bone-marrow cells could regenerate nerve cells in the brains of human stem-cell recipients. These early findings, if confirmed in future research, have implications for the treatment of neurodegenerative disorders such as Parkinson's disease.
Gastritis produced by acetyl-salicylic acid consumption is a common disorder worldwide. The use of probiotics has been proposed to ameliorate different gastrointestinal tract diseases such as inflammatory bowel disease, diarrhea, irritable bowel syndrome, etc. However, little attention has been paid to the use of probiotics in gastric disease.
Patients who have had total joint replacement (TJR) are expected to return to their physician's office or clinic regularly for routine follow-up care. In a new study presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS), researchers asked 210 TKR patients to either complete a Web-based follow-up, which included an online survey and an X-ray taken at the nearest Internet-enabled facility; or, to return to the clinic/office for their regular appointment.
A new study finds that many women with breast cancer take antioxidant supplements while undergoing cancer treatment, even though the consequences of doing so are unknown.
DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today presented updated clinical data from its Phase I/II study of lead product candidate VAL-083 (dianhydrogalactitol), in patients with refractory glioblastoma multiforme (GBM), at GBM2015: 2nd International Symposium on Clinical and Basic Investigation in Glioblastoma in Toledo, Spain.
› Verified 4 days ago